Equitable access to COVID-19 vaccine distribution – the case of the Andean Community

Dhanay Cadillo Chandler*, Jouko Nuotila*, Rosa Maria Ballardini

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review


The COVID-19 pandemic has shown how equitable vaccine distribution still remains unaccomplished. While access to COVID-19 vaccines has been efficient in the EU, the Latin American situation is very different. For example, the Andean Community reports that, as of December 2022, 83% of the population had received at least the first dose of the vaccine while only 43% had received the third dose (http://www.orasconhu.org). Motivated by the challenges and successes endured by countries in the Andean Community vis-à-vis the EU during COVID-19 vaccine roll-outs, we analyse key legal, policy and management factors affecting vaccine equity. We are especially critical of the strategy followed in the Andean Community, namely, of increasing dependency on imports and donations instead of harnessing other more effective policies. We highlight the specific role of the factors identified in achieving coherent policy strategies and propose recommendations to promote equitable vaccine distribution in the Andean Community, and beyond.
Original languageEnglish
Peer-reviewed scientific journalJournal of Strategic Contracting and Negotiation
Publication statusPublished - 22.11.2023
MoE publication typeA1 Journal article - refereed


  • 513 Law
  • Andean Community
  • Vaccine Equity
  • Governance
  • Technological innovation
  • Intellectual Property Rights (IPR)

Areas of Strength and Areas of High Potential (AoS and AoHP)

  • AoS: Financial management, accounting, and governance
  • AoHP: Digitisation and sustainability in intellectual property


Dive into the research topics of 'Equitable access to COVID-19 vaccine distribution – the case of the Andean Community'. Together they form a unique fingerprint.

Cite this